Clinical Trials in Philadelphia

Showing 9901-9920 of 20,904 trials

Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH).

NCT03338998

This is a randomized, placebo-controlled, subject and investigator-blinded study to evaluate efficacy, safety and tolerability of BAF312 in participants with intracerebral hemorrhage (ICH)

Hemorrhagic StrokeIntracerebral Hemorrhage (ICH)

Novartis Pharmaceuticals32 participantsStarted Dec 2017

Palo Alto, California, United States • New Haven, Connecticut, United States • Atlanta, Georgia, United States +8 more locations

COMPLETEDPhase 3< 1 mile

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer

NCT00087178

RATIONALE: Drugs used in chemotherapy, such as fluorouracil, epirubicin, cyclophosphamide, and doxorubicin, work in different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which combination chemotherapy regimen is more effective in treating breast cancer. PURPOSE: This randomized phase III trial is studying two combination chemotherapy regimens to compare how well they work in treating women who have undergone surgery for breast cancer that has not spread to the lymph nodes.

Breast Cancer

NSABP Foundation Inc2,722 participantsStarted May 2004

Huntsville, Alabama, United States • Anchorage, Alaska, United States • Glendale, Arizona, United States +603 more locations

Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH).

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer

Find Trials by Condition in Philadelphia

Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

A Study to Evaluate the Safety and Efficacy of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Participants With High Grade Primary Central Nervous System (CNS) Malignancies

A Study of LY3561774 in Participants With Dyslipidemia

Exparel Use in Peripheral Nerve Blocks and Local Infiltration for Foot and Ankle Surgery: A Randomized Controlled Trial

Developing Mental Health Supports for Autistic Students

ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19

Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)

A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis

A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood

Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy

PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients

A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)

Genetics of Primary Ciliary Dyskinesia

Study of Tisagenlecleucel in Combination With Pembrolizumab in r/r Diffuse Large B-cell Lymphoma Patients

Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A